Aidapak Recalls Disopyramide Phosphate Capsules Due to Potential Labeling Error
Aidapak Services, LLC is recalling Disopyramide Phosphate capsules because they may have been mislabeled as Thyroid tablets. The error could lead to patients receiving the wrong medication.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves situations that may cause temporary or medically reversible health issues. The hazard is a labeling error (mislabeling) which poses a risk of incorrect medication administration, but no specific injuries or illnesses are reported in the source text.
Plain-English summary
Aidapak Services, LLC is recalling Disopyramide Phosphate, Capsule, 150 mg (NDC 00093312901) due to a labeling error. The recall was initiated because the product may have been mislabeled as Thyroid, Tablet, 30 mg (NDC 00456045801). Both products share the same pedigree code (AD65323) and expiration date (5/29/2014), increasing the risk of confusion.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The specific lot code for the recalled Disopyramide Phosphate is AD65323_4. The mislabeled Thyroid tablets are identified by pedigree AD65323_1.
Healthcare providers and patients should check their inventory and prescriptions for Disopyramide Phosphate capsules with the specified pedigree and expiration date. If the product is found, it should be returned to the pharmacy or healthcare provider for replacement or refund. Patients should not take the medication if they suspect it may be mislabeled and should consult their healthcare provider for appropriate treatment.
The recalled product
- Product
- DISOPYRAMIDE PHOSPHATE, Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093312901.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- DISOPYRAMIDE PHOSPHATE
- Capsule
- 150 mg has the following codes: Pedigree: AD65323_4
- EXP: 5/29/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereFDA Recalls Potentially Mislabeled Losartan Potassium Tablets
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Phosphorus Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Disulfiram Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Irbesartan Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateFDA Recalls Zinc Sulfate Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- HighAidapak Recalls Isosorbide Mononitrate Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22